PepGen Inc. (PEPG)
2.36
-0.05
(-2.07%)
USD |
NASDAQ |
Oct 30, 16:00
2.345
-0.02
(-0.64%)
After-Hours: 20:00
PepGen Cash from Operations (Quarterly) : -15.81M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -15.81M |
| March 31, 2026 | -18.43M |
| December 31, 2025 | -15.84M |
| September 30, 2025 | -19.26M |
| June 30, 2025 | -23.60M |
| March 31, 2025 | -22.93M |
| December 31, 2024 | -19.48M |
| September 30, 2024 | -24.01M |
| June 30, 2024 | -16.35M |
| March 31, 2024 | -22.53M |
| December 31, 2023 | -19.42M |
| September 30, 2023 | -16.48M |
| Date | Value |
|---|---|
| June 30, 2023 | -17.68M |
| March 31, 2023 | -15.42M |
| December 31, 2022 | -13.39M |
| September 30, 2022 | -20.97M |
| June 30, 2022 | -12.64M |
| March 31, 2022 | -12.27M |
| December 31, 2021 | -5.986M |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | -2.83M |
| December 31, 2020 | -0.088M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Korsana Biosciences, Inc. | -1.432M |
| IRulya Therapeutics, Inc. | -18.89M |
| Q32 Bio, Inc. | -3.075M |
| Bridgebio Oncology Therapeutics, Inc. | -44.36M |
| Arrowhead Pharmaceuticals, Inc. | -177.47M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -3.516M |
| Cash from Financing (Quarterly) | -0.065M |
| Free Cash Flow | -69.46M |
| Free Cash Flow Per Share (Quarterly) | -0.2288 |
| Free Cash Flow to Equity (Quarterly) | -15.37M |
| Free Cash Flow to Firm (Quarterly) | -15.84M |
| Free Cash Flow Yield | -48.76% |